Israeli tech had one of those weeks that captures the market’s current contradiction. On one side, capital is still flowing into high-conviction categories like defense-tech, AI commerce, biotech
Press ↩ to search · Esc to close · ⌘K to open anywhere
Cookies on IsraelVC
We use essential cookies to keep the site working. We’d also like to use analytics cookies to understand how founders and fund managers use IsraelVC so we can improve it. Analytics only loads if you agree.
